Home > Income Statement > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Total Expenditure

    Back to Income Statement
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

NATH BIOGENES (INDIA) Last 5 Year Total Expenditure History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2013
Total Expenditure ₹315 Cr₹283 Cr₹252 Cr₹241 Cr₹118 Cr

What is the latest Total Expenditure of NATH BIOGENES (INDIA) ?

The latest Total Expenditure ratio of NATH BIOGENES (INDIA) is ₹315 Cr based on Mar2025 Consolidated results.
Year Total Expenditure
Mar2025₹315 Cr
Mar2024₹283 Cr
Mar2023₹252 Cr
Mar2022₹241 Cr
Mar2013₹118 Cr

How is Total Expenditure of NATH BIOGENES (INDIA) Trending?

Years Total Expenditure % Change
Mar2025 ₹315 Cr
11.42
Mar2024 ₹283 Cr
12.00
Mar2023 ₹252 Cr
4.66
Mar2022 ₹241 Cr
104.70
Mar2013 ₹118 Cr -

Compare Total Expenditure of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹272.7 Cr -3.5% -6.1% -6.9% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹10,752.5 Cr -3.9% -15.5% -11.5% Stock Analytics
KAVERI SEED COMPANY ₹3,941.3 Cr -0.4% -8.6% -22.2% Stock Analytics
VENKYS (INDIA) ₹1,857.2 Cr -3% -13.1% -24% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹845.5 Cr -5.5% -13.6% -36.6% Stock Analytics
INDO US BIOTECH ₹213.7 Cr 3.4% -22.3% -47.1% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

-3.5%

-6.1%

-6.9%

SENSEX

-0.2%

-7.2%

3.5%


You may also like the below Video Courses